| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/01/2006 | EP1127355B1 Products and methods for brachytherapy |
| 03/01/2006 | EP1098638B1 Use of a glucose uptake enhancer for reducing post-ischemic injury of the heart |
| 03/01/2006 | EP1051168B1 Compositions for facilitating surgical procedures |
| 03/01/2006 | EP1017382B1 Biarylalkanoic acids as cell adhesion inhibitors |
| 03/01/2006 | EP0998569B1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| 03/01/2006 | EP0931148B1 Fibroblast growth factor homologs |
| 03/01/2006 | CN1741999A Pyridazinone derivatives as GSK-3beta inhibitors |
| 03/01/2006 | CN1741996A Carboxamide derivatives and their use as factor XA inhibitors |
| 03/01/2006 | CN1741990A Arylalkylcarbamate derivatives production and use thereof in therapy |
| 03/01/2006 | CN1741820A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/01/2006 | CN1741819A Sustained release composition for oral administration of drugs |
| 03/01/2006 | CN1740787A Method for measuring total flavone content in compositions extracted from gingko biloba leaves |
| 03/01/2006 | CN1740786A Method for measuring tepene lactone content in compositions extracted from Ginkgo biloba leaves |
| 03/01/2006 | CN1740197A Recombination interferon with new space conformation and enhanced effect, its preparing method and application |
| 03/01/2006 | CN1740182A Novel bisamidate phosphonate prodrugs |
| 03/01/2006 | CN1740151A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 03/01/2006 | CN1740150A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 03/01/2006 | CN1739800A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 03/01/2006 | CN1739788A Modulation of TRIP-BR function and method of treating proliferative disorders |
| 03/01/2006 | CN1739787A Orally administered peptides to ameliorate atherosclerosis |
| 03/01/2006 | CN1739780A Miao medicine for treating tuberculosis and rheumatic heart disease and its compounding process and usage |
| 03/01/2006 | CN1739764A Chinese medicine for lowering blood pressure and reducing blood fat and its prepn |
| 03/01/2006 | CN1739744A Production process of flavone compound powder |
| 03/01/2006 | CN1739742A Chinese medicine capsule for treating cardiac and cerebral vascular diseases and its production process |
| 03/01/2006 | CN1739741A Medicine for treating coronary heart disease and its prepn |
| 03/01/2006 | CN1739728A Medicine composition for treating cardiac and cerebral vascular diseases and its prepn |
| 03/01/2006 | CN1739698A Chinese medicine for treating cardiac and cerebral blood supply insufficiency and its prepn |
| 03/01/2006 | CN1739673A Hypertension treating Chinese medicine composition |
| 03/01/2006 | CN1739672A Pile treating Chinese medicine prepn and its production process |
| 03/01/2006 | CN1739654A Chinese medicine composition for treating cardiac and cerebral vascular diseases and its prepn |
| 03/01/2006 | CN1739642A Medicine composition for treating apoplexy and chest Bi-syndrome and its prepn |
| 03/01/2006 | CN1739618A Heart disease treating Chinese medicine prepn and its prepn process and quality control method |
| 03/01/2006 | CN1739606A Active extract composition of epimedium and red sage and its medicinal use |
| 03/01/2006 | CN1739594A Nao'an oral liquid and its prepn |
| 03/01/2006 | CN1739593A New use of Herba siegesbeckiae extract |
| 03/01/2006 | CN1739591A New-type slowly releasing solid Naolilong prepn |
| 03/01/2006 | CN1739590A Dispersion tablet containing notoginseng total saponin and its prepn |
| 03/01/2006 | CN1739588A Chinese medicine prepn for treating cardiac vascular diseases and its prepn |
| 03/01/2006 | CN1739585A Effective part prepn for treating cardiac and cerebral vascular diseases and its prepn process |
| 03/01/2006 | CN1739561A Application of high permeability medicine composition in preparing pre-nacrosis medicine |
| 03/01/2006 | CN1739549A Prepn process of active medicinal lignin matter and its use in treating cardiac vascular diseases |
| 03/01/2006 | CN1739545A Pueraria flavone micro pill prepn and its prepn process |
| 03/01/2006 | CN1739544A Chinese medicine prepn fo treating cardiac vascular diseases and its prepn process and quality control method |
| 03/01/2006 | CN1739537A Cyclodextrin clathrate of breviscapine and its prepn |
| 03/01/2006 | CN1739535A Notoginseng seponin-sodium chloride injection and its prepn |
| 03/01/2006 | CN1739533A Oral disintegrating notoginseng total saponin tablet and its prepn process |
| 03/01/2006 | CN1739532A American ginseng-gynostemma pentaphylla total saponin prepn |
| 03/01/2006 | CN1739525A Nanometer partical administration system of prostaglandin E1 coated with polyglycol derived phospholipid |
| 03/01/2006 | CN1739512A Milrinone composition for injection and its prepn |
| 03/01/2006 | CN1739503A Compound medicine of ozagrel and its salt and troxerutin |
| 03/01/2006 | CN1739500A (-)-epigallocatechin gallate-magnesium complex solid dispersion and its prepn and application |
| 03/01/2006 | CN1739499A (-)-epigallocatechin gallate solid dispersion and its prepn and application |
| 03/01/2006 | CN1739496A Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders |
| 03/01/2006 | CN1243770C Neurotrophic growth factor |
| 03/01/2006 | CN1243754C New process for the production of 9-oxa-3,7-diazobicyclic(3.3.1) nonane |
| 03/01/2006 | CN1243751C Piperidine compounds as anti-allergic medicine |
| 03/01/2006 | CN1243741C Quinolinyl and benzothiazolyc PPAR-gamma modulators |
| 03/01/2006 | CN1243736C Process for preparation of 3-spiro'cyclohexam-1, 3'-'3H indolin-2'-one derivatives |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 03/01/2006 | CN1243730C Cinnamoylaminoalkyl-substd. benzenesulfonamide derivs. |
| 03/01/2006 | CN1243724C Amide derivatives which are useful as cell factor inhibitors |
| 03/01/2006 | CN1243554C Heart protecting nutrient mixture of total seabuckthorn fruit flavone |
| 03/01/2006 | CN1243552C Functional medical wine for treating various diseases |
| 03/01/2006 | CN1243550C Pharmaceutical compositions and uses for androst-5-ene-3beta, 17 beta-diol and use thereof |
| 03/01/2006 | CN1243541C 2-(alpha-hydroxypentyl) benzoate and its preparing process and usage |
| 02/28/2006 | US7005553 such as 2-nitrophenol by reacting 3-hydroxy-4-methoxybenzophenone with alkyl nitrate in presence of regioselective acid catalyst (sulfuric acid) |
| 02/28/2006 | US7005538 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; use to treat cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism |
| 02/28/2006 | US7005508 Nitroderivatives of polysaccharides |
| 02/28/2006 | US7005452 administering enantiomorphs comprising (Z(+-)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide hydrochloride), as serotonin and adrenergic uptake inhibitors, with side effect reduction; antidepressants |
| 02/28/2006 | US7005440 Therapeutic uses of tri-aryl acid derivatives |
| 02/28/2006 | US7005438 Pharmaceutically active isoindoline derivatives |
| 02/28/2006 | US7005436 Heterocyclo inhibitors of potassium channel function |
| 02/28/2006 | US7005434 Compounds and uses thereof |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | US7005425 Administering a minimal dose of an Al adenosine receptor agonist in conjunction with a minimal dose of a beta blocker, calcium channel blocker, or cardiac glycoside |
| 02/28/2006 | US7005415 Wherein the DNA synthesis promoting activity of the heparin-binding protein is increased by the covalently bonded sugar chain which can be heparan sulfate; improved in vivo stabilities such as acid resistance and alkali resistance |
| 02/28/2006 | US7005285 Human p21-activated kinase 5 polypeptide |
| 02/28/2006 | US7004945 Devices and methods for the restoration of a spinal disc |
| 02/28/2006 | CA2347469C Esters of (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 100,907 |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/23/2006 | WO2006019169A1 3-epivitamin d3 derivative and therapeutic agent containing the same |
| 02/23/2006 | WO2006018657A1 Hdac inhibitors and methods of use thereof |
| 02/23/2006 | WO2006017921A1 Selective muscle relaxant and pharmaceutical compositions |
| 02/23/2006 | WO2006007671A3 Therapeutically combinations |
| 02/23/2006 | WO2005069771A3 Small molecule antagonists of bcl-2 family proteins |
| 02/23/2006 | WO2004067018A8 Bioavailability enhancing activity of carum carvi extracts and fractions thereof |
| 02/23/2006 | WO2004043383A3 A new target for angiogenesis and anti-angiogenesis therapy |
| 02/23/2006 | US20060041164 liver X receptor LXR agonists; increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, cardiovascular disease, inflammation; 2-(3-{3-[[2-Chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino]-2-methyl-propoxy}-phenyl)acetic acid methyl ester |
| 02/23/2006 | US20060041130 Syntheses of quinazolinones |
| 02/23/2006 | US20060041007 Metastable benzoxepne derivatives which can be used in the treatment of dyslipidaemia a therosclerosis and diabetes, pharmaceutical compositions comprising them and processes for the preparation thereof |
| 02/23/2006 | US20060040992 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 02/23/2006 | US20060040989 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 02/23/2006 | US20060040979 3-Aryl-2-hydroxypropionic acid derivative I |
| 02/23/2006 | US20060040976 Thiobenzimidazole derivatives |
| 02/23/2006 | US20060040969 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4 |
| 02/23/2006 | US20060040964 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders |
| 02/23/2006 | US20060040963 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/23/2006 | US20060040959 Adenosine A3 receptor modulators |
| 02/23/2006 | US20060040957 Bicyclic pyrimidine matrix metalloproteinase inhibitors |
| 02/23/2006 | US20060040956 Substituted alkylamine derivatives and methods of use |